Jing Yang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Respiratory Syndrome Coronavirus

Top Venues

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Guiming Li, Wenjun Zhang, Jing Yang
Time - The fourth dimension of immune cells. MedComm 5 (8) (2024)
Guiming Li, Wenjun Zhang, Jing Yang
Time - The fourth dimension of immune cells. MedComm 5 (8) (2024)
Yiying Xue, Husheng Mei, Yisa Chen, James D Griffin, Qingsong Liu, Ellen Weisberg, Jing Yang
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2. MedComm 4 (3) (2023)
Yiying Xue, Husheng Mei, Yisa Chen, James D Griffin, Qingsong Liu, Ellen Weisberg, Jing Yang
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2. MedComm 4 (3) (2023)
Yisa Chen, Yiying Xue, Jing Yang
Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19. Journal of medical virology (2023)
Jing Yang, Ellen L Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Zuowei Wang, Chengcheng Meng, Shengzhe Zhang, Mingqi Hou, Ziping Qi, Aoli Wang, Yunyun Jiang, Zongru Jiang, Tao Huang, Qingwang Liu, Robert S Magin, Laura Doherty, Wenchao Wang, Jing Liu, Sara J Buhrlage, Qing-Song Liu, James D Griffin
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2. Leukemia 36 (4) (2022)
Jing Yang, Ellen L Weisberg, Xiaoxi Liu, Robert S Magin, Wai Cheung Chan, Bin Hu, Nathan J Schauer, Shengzhe Zhang, Ilaria Lamberto, Laura Doherty, Chengcheng Meng, Martin Sattler, Lucia Cabal-Hierro, Eric Winer, Richard Stone, Jarrod A Marto, James D Griffin, Sara J Buhrlage
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia (2021)